Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
758.740.73%
QQQ
705.661.29%
BTC/USD
78425.002.1161%
DIA
523.670.4%
GLD
391.431.84%
TLT
80.560.39%

TriSalus Life Sciences Inc (TLSI) Stock Price, Quote, News & History

TLSINASDAQ
Trade with Public
Trade with Public
$4.68
0.0150.32%
Last update: Sep 14, 10:28 AM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

TriSalus Life Sciences (TLSI) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$4.63
Close
-
Volume / Avg.
6.52K / 278.57K
Day Range
$4.58 - $4.71
52 Wk Range
2.20 - 7.95
Market Cap
$288.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
7.91%
Days to Cover
35.88

Recent TriSalus Life Sciences Inc News

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiate coverage: Buy ratings for Robinhood ($170), TriSalus ($11), Kodiak AI ($8); Underperform for Deckers ($70).
Avi Kapoor

Nasdaq Surges Over 1%; Alibaba Shares Gain After Q4 Results

US stocks mixed, Nasdaq up 200 points. Dow down 0.43%, Nasdaq up 0.79%, S&P 500 up 0.27%. Communication services up 1.6%, utilities down 1.4%. Alibaba shares up 6% after reporting mixed Q4 results. Velo3D up 47%, Wix.com down 30%, National Vision down 25%.
Avi Kapoor

Dow Falls 200 Points; US Producer Prices Surge In April

US stocks mixed as Dow drops over 200 points on opening. Nasdaq up 0.13%, S&P 500 down 0.13%. Tech sector up 0.4%, utilities down 1.7%. PPI rose 1.4% in April.
Avi Kapoor

3 Stocks With Robust Growth Outlooks Insiders Are Buying

Insider buying is a flimsy market signal without some other catalyst to drive the price action. In the case of TriSalus Life Sciences (NASDAQ:TLSI), Avadel Pharmaceuticals (NASDAQ:AVDL), and Smithfield Foods
MarketBeat

This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-22.80M
Investing Cash Flow (TTM)
-440.00K
Financing Cash Flow (TTM)
42.69M
Free Cash Flow (TTM)
-23.28M
Capital Expenditure (TTM)
-480.00K
Net Change in Cash (TTM)
19.45M

Analyst Trends and Forecast

1
May
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$276.92M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
5.20
PB Ratio (TTM)
44.09
Earnings Yield % (TTM)
-28.36%
Earnings Yield % (FWD)
-5.97%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.11

Company Debt

Total Debt
$33.07M
LT Debt
$33.07M
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-$36.00K
Total Cash
$46.29M
Debt to Equity
5.26
Issuance of Debt (TTM)
-$36.00K
Repayment of Debt (TTM)
-$36.00K

Key Statistics

Open
$4.63
Close
-
Volume / Avg.
6.52K / 278.57K
Day Range
$4.58 - $4.71
52 Wk Range
2.20 - 7.95
Market Cap
$288.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
7.91%
Days to Cover
35.88

About

Sector
Health Care
Industry
Biotechnology
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, f...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy TriSalus Life Sciences (TLSI) stock?

A

You can purchase shares of TriSalus Life Sciences (NASDAQ:TLSI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TriSalus Life Sciences (TLSI) competitors?

Q

What is the forecast, or price target, for TriSalus Life Sciences (TLSI) stock?

A

TriSalus Life Sciences has a consensus price target of $10.61.

Q

What is the current price for TriSalus Life Sciences (TLSI)?

A

The stock price for TriSalus Life Sciences (NASDAQ: TLSI) is $4.68 last updated September 14, 2026 at 10:28 AM EDT.

Q

Does TriSalus Life Sciences (TLSI) pay a dividend?

A

There are no upcoming dividends for TriSalus Life Sciences.

Q

When is TriSalus Life Sciences (NASDAQ:TLSI) reporting earnings?

A

TriSalus Life Sciences does not have any upcoming earnings scheduled.

Q

Is TriSalus Life Sciences (TLSI) going to split?

A

There is no upcoming split for TriSalus Life Sciences.

Q

What sector and industry does TriSalus Life Sciences (TLSI) operate in?

A

TriSalus Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved